Landmark population (358 events / 572 patients) | |||
---|---|---|---|
HRa | (95% CI) | P | |
Chemotherapy-induced neutropenia | 0.048 | ||
Grade 1–2 vs 0 | 1.21 | (0.92–1.58) | |
Grade 3–4 vs 0 | 0.71 | (0.53–0.95) | |
Age (continuous) | 1.03 | (1.01–1.05) | 0.002 |
Gender | 0.066 | ||
Female vs Male | 0.77 | (0.58–1.01) | |
Performance status | 0.181 | ||
2 vs 0–1 | 1.98 | (0.73–5.39) | |
Stage | 0.156 | ||
IV vs IIIB | 1.29 | (0.91–1.82) | |
Histology | 0.13 | ||
Non squamous vs Squamous | 0.91 | (0.68–1.20) | |
Undefined vs Squamous | 1.27 | (0.89–1.81) |